Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Invested Capital (2021 - 2024)

Historic Invested Capital for Pharmaceuticals (CASI) over the last 4 years, with Q4 2024 value amounting to $20.2 million.

  • Pharmaceuticals' Invested Capital fell 1625.91% to $20.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $20.2 million, marking a year-over-year decrease of 1625.91%. This contributed to the annual value of $20.2 million for FY2024, which is 1625.91% down from last year.
  • Per Pharmaceuticals' latest filing, its Invested Capital stood at $20.2 million for Q4 2024, which was down 1625.91% from $24.2 million recorded in Q4 2023.
  • In the past 5 years, Pharmaceuticals' Invested Capital ranged from a high of $32.2 billion in Q2 2023 and a low of $20.2 million during Q4 2024
  • In the last 4 years, Pharmaceuticals' Invested Capital had a median value of $44.6 million in 2022 and averaged $6.5 billion.
  • In the last 5 years, Pharmaceuticals' Invested Capital plummeted by 4725.1% in 2022 and then plummeted by 1625.91% in 2024.
  • Over the past 4 years, Pharmaceuticals' Invested Capital (Quarter) stood at $84.5 million in 2021, then plummeted by 47.25% to $44.6 million in 2022, then crashed by 45.79% to $24.2 million in 2023, then fell by 16.26% to $20.2 million in 2024.
  • Its Invested Capital was $20.2 million in Q4 2024, compared to $24.2 million in Q4 2023 and $32.2 billion in Q2 2023.